Pseudohypoparathyroidism historical perspective: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
=Overview= | =Overview= | ||
In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of [[Albright's hereditary osteodystrophy|Albright hereditary osteodystrophy.]] | In 1942, Fuller albright, an American [[endocrinologist]], first discovered pseudohypoparathyroidim and associated clinical features of [[Albright's hereditary osteodystrophy|Albright hereditary osteodystrophy.]] | ||
==Historical Perspective== | ==Historical Perspective== | ||
*In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.<ref>{{cite journal |vauthors=Albright F, Burnett CH, Smith PH, Parson |date=1942 |title=Pseudohypoparathyroidism- An example of ‘Seabright-Bantam syndrome’ |url= |journal= Endocrinology |volume=30 |issue= |pages=922–32 |doi= |access-date= }}</ref> | *In 1942, Fuller albright, an American [[endocrinologist]], first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.<ref>{{cite journal |vauthors=Albright F, Burnett CH, Smith PH, Parson |date=1942 |title=Pseudohypoparathyroidism- An example of ‘Seabright-Bantam syndrome’ |url= |journal= Endocrinology |volume=30 |issue= |pages=922–32 |doi= |access-date= }}</ref> | ||
*In the same year, [[Albright's hereditary osteodystrophy|Albright hereditary osteodystrophy]] was clinically described together with pseudohypoparathyroidism. <ref name="pmid5002252">{{cite journal |vauthors=Eyre WG, Reed WB |title=Albright's hereditary osteodystrophy with cutaneous bone formation |journal=Arch Dermatol |volume=104 |issue=6 |pages=634–42 |year=1971 |pmid=5002252 |doi= |url=}}</ref> | *In the same year, [[Albright's hereditary osteodystrophy|Albright hereditary osteodystrophy]] was clinically described together with pseudohypoparathyroidism. <ref name="pmid5002252">{{cite journal |vauthors=Eyre WG, Reed WB |title=Albright's hereditary osteodystrophy with cutaneous bone formation |journal=Arch Dermatol |volume=104 |issue=6 |pages=634–42 |year=1971 |pmid=5002252 |doi= |url=}}</ref> | ||
Revision as of 18:12, 17 October 2017
|
Pseudohypoparathyroidism Microchapters |
|
Differentiating Pseudohypoparathyroidism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pseudohypoparathyroidism historical perspective On the Web |
|
American Roentgen Ray Society Images of Pseudohypoparathyroidism historical perspective |
|
Risk calculators and risk factors for Pseudohypoparathyroidism historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overview
In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of Albright hereditary osteodystrophy.
Historical Perspective
- In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.[1]
- In the same year, Albright hereditary osteodystrophy was clinically described together with pseudohypoparathyroidism. [2]